Laboratory proficiency testing involves standardized evaluation of a laboratory’s performance through analysis of unknown test samples provided by an external source. It helps laboratories verify competence and identify the need for process improvement through objective comparison with peer groups. Proficiency testing has become essential for laboratories engaged in areas like food safety testing, water quality testing, clinical pathology testing and forensic toxicology to ensure accurate and reliable results. The samples can contain substances like pathogens, contaminants, therapeutic drugs or biomarkers and are designed to challenge various aspects of a laboratory’s capabilities. Participation in proficiency testing schemes aids in compliance with regulatory and accreditation requirements. Global accreditation and conformity assessment bodies have made it mandatory to demonstrate testing proficiency through successful external quality assessments.
The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increased adoption of Lab proficiency testing in clinical labs and hospitals has emerged as a key trend. Healthcare facilities are more focused on improving testing quality to deliver accurate patient diagnosis and treatment. Digital proficiency testing involving electronic sample and report distribution through online platforms has gained popularity. It allows remote participation and provides instant assessment reports. Growing healthcare expenditure in emerging nations is raising quality control investments in their medical laboratories and driving proficiency testing uptake. Biotechnology and life sciences organizations are also contributing to market growth through outsourced quality checks of in-vitro diagnostic products and reagents. Industry leaders are expanding their service portfolios and geographical presence to tap new revenue streams in evolving markets.
Laboratory Quality Assurance Drives the Clinical Diagnostic Proficiency Testing Market
Clinical diagnostic proficiency testing helps ensure accuracy and reliability of patient test results through standardized evaluation of clinical laboratory performance in analyzing unknown test samples. It addresses the need for objective assessment and comparison in areas like clinical chemistry, hematology, microbiology and molecular diagnostics testing performed at hospitals, clinics and independent pathology labs. Proficiency testing samples may contain substances like therapeutic drugs, biomarkers, infectious pathogens or formulated samples designed to challenge different aspects of a lab’s testing procedures. Participating in external quality assessment programs aids regulatory compliance and accreditation needed for labs performing diagnostic testing. The global Clinical Diagnostic Proficiency Testing Market is estimated to be valued at US$ 1.29 Bn in 2024 and is expected to exhibit a CAGR of
Porter’s Analysis
Threat of new entrants: The laboratory proficiency testing market requires significant capital investments and regulatory compliances which limit new entrants.
Bargaining power of buyers: Buyers have moderate bargaining power due to the presence of multiple manufacturers and service providers in the market.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to availability of alternatives.
Threat of new substitutes: There is low threat from substitutes as laboratory proficiency testing is required to validate quality standards in labs.
Competitive rivalry: The market is moderately competitive due to presence of large number of local and regional players.
Key Takeaways
The Global Laboratory Proficiency Testing Market Size is expected to witness high growth.
Regional analysis: North America dominates the market led by U.S. and Canada. Large presence of major players and stringent regulations regarding laboratory quality drive the North America market. Asia Pacific is expected to witness fastest growth over the forecast period due to growing healthcare expenditure, improving healthcare infrastructure and regional expansions by manufacturers.
Key players: Key players operating in the laboratory proficiency testing market are RxBio Inc., Annova Chem Inc., Medicom Healthcare Ltd., Onconova Therapeutics, Genome Protection Inc., Grace Therapeutics LLC, Amgen Inc., Partner Therapeutics Inc., Jubilant Life Sciences Ltd., Cipla Inc., Stium Inc., Soligenix Inc., Aeolus Pharmaceuticals, PharmaIN Corp, Immune Modulators Inc. RxBio Inc. and Amgen Inc. are the leaders in the market with strong regional presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it